{"id":70789,"date":"2026-05-12T11:08:40","date_gmt":"2026-05-12T11:08:40","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70789"},"modified":"2026-05-21T07:14:09","modified_gmt":"2026-05-21T07:14:09","slug":"ahk-cu","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/ahk-cu\/","title":{"rendered":"AHK-Cu"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je AHK-Cu?<\/h3>\n<p style=\"margin: 0;\"><strong>AHK-Cu<\/strong> (Alanyl-Histidyl-Lysin M\u011b\u010f(II) komplex) je syntetick\u00fd tripeptid v\u00e1zaj\u00edc\u00ed m\u011b\u010f a sestersk\u00e1 molekula k <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a>. Zat\u00edmco GHK-Cu je kanonick\u00fd m\u011b\u010f-peptid pro k\u016f\u017ei a hojen\u00ed ran, v\u00fdzkumn\u00fd sign\u00e1l AHK-Cu je soust\u0159ed\u011bn v <strong>biologii vlasov\u00fdch folikul\u016f<\/strong> \u2014 publikovan\u00e9 preklinick\u00e9 pr\u00e1ce dokumentuj\u00ed stimulaci derm\u00e1ln\u00edch papil\u00e1rn\u00edch bun\u011bk, zv\u011bt\u0161en\u00ed folikul\u016f, zv\u00fd\u0161enou vaskularizaci folikul\u016f a prodlou\u017een\u00ed anagenn\u00ed r\u016fstov\u00e9 f\u00e1ze. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch o obsahu 20 mg a 50 mg pouze pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">110374-12-4 (AHK-Cu); 71567-06-1 (AHK voln\u00fd peptid)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub> (1:1 m\u011b\u010fn\u00fd komplex)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~417 Da (m\u011b\u010fn\u00fd komplex)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ala-His-Lys (AHK, 3 aminokyseliny) koordinovan\u00e9 s jednou atomem Cu<sup>2+<\/sup> iont p\u0159es imidazolov\u00fd dus\u00edk His, aminov\u00fd konec Ala a deprotonovan\u00fd peptidov\u00fd dus\u00edk mezi Ala a His<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd komplex m\u011b\u010f-peptid (modr\u00fd a\u017e modrofialov\u00fd pr\u00e1\u0161ek; barva poch\u00e1z\u00ed z d-d p\u0159echod\u016f v\u00e1zan\u00e9 Cu<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00e9: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00e9: 2\u20138 \u00b0C, pou\u017eijte do ~30 dn\u016f. Chra\u0148te p\u0159ed sv\u011btlem. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed. Rozpustn\u00fd ve vod\u011b; rozpu\u0161t\u011bn\u00fd roztok si zachov\u00e1v\u00e1 charakteristickou modrou barvu v\u00e1zan\u00e9 Cu<sup>2+<\/sup>.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Co je AHK-Cu?<\/h2>\n<p><strong>AHK-Cu<\/strong> (Komplex alanyl-histidyl-lysin s m\u011bd\u00ed(II)) je syntetick\u00fd tripeptid v\u00e1zaj\u00edc\u00ed m\u011b\u010f slo\u017een\u00fd ze t\u0159\u00ed aminokyselin Ala, His a Lys, koordinovan\u00fd s jedn\u00edm Cu<sup>2+<\/sup> iontem. Je to sestersk\u00e1 molekula v\u00edce studovan\u00e9 <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> \u2014 ob\u011b pat\u0159\u00ed do t\u0159\u00eddy \u201cm\u011b\u010fn\u00fdch peptid\u016f\u201d, ob\u011b sd\u00edlej\u00ed stejnou architekturu koordinace Cu pomoc\u00ed histidinov\u00e9ho zbytku a ob\u011b jsou studov\u00e1ny v dermatologick\u00fdch v\u00fdzkumn\u00fdch kontextech. Rozd\u00edl je v prim\u00e1rn\u00edm v\u00fdzkumn\u00e9m sign\u00e1lu: GHK-Cu je kanonick\u00fd v\u00fdzkumn\u00fd peptid pro remodelaci k\u016f\u017ee, hojen\u00ed ran a opravu pojivov\u00e9 tk\u00e1n\u011b, zat\u00edmco nej\u010dast\u011bji citovan\u00e9 v\u00fdzkumn\u00e9 aplikace AHK-Cu jsou v <strong>biologii vlasov\u00fdch folikul\u016f<\/strong>.<\/p>\n<p>Dob\u0159e charakterizovan\u00e9 molekul\u00e1rn\u00ed slo\u017een\u00ed je C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub>, molekulov\u00e1 hmotnost p\u0159ibli\u017en\u011b 417 Da. Cu<sup>2+<\/sup> iont se koordinuje s tripeptidem p\u0159es imidazolov\u00fd dus\u00edk histidinu, aminov\u00fd konec alaninu a deprotonovan\u00fd peptidov\u00fd dus\u00edk mezi Ala a His \u2014 stejn\u00e1 \u010dtvercov\u011b plan\u00e1rn\u00ed koordina\u010dn\u00ed geometrie jako u GHK-Cu. V\u00e1zan\u00e1 m\u011b\u010f dod\u00e1v\u00e1 ob\u011bma slou\u010denin\u00e1m jejich charakteristickou modrofialovou barvu v pevn\u00e9m i rozpu\u0161t\u011bn\u00e9m stavu \u2014 v\u00fdzkumn\u00edci rekonstituuj\u00edc\u00ed AHK-Cu by m\u011bli o\u010dek\u00e1vat viditeln\u011b modr\u00fd pracovn\u00ed roztok.<\/p>\n<p>AHK-Cu je dod\u00e1v\u00e1n jako vysoce \u010dist\u00fd lyofilizovan\u00fd komplex m\u011b\u010f-peptid pro rekonstituci s bakteriostatickou vodou. Tato slou\u010denina nen\u00ed <strong>FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. V\u00fdzkumn\u00fd DSIP prod\u00e1van\u00fd zde je dod\u00e1v\u00e1n<\/strong> FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem schv\u00e1lena pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. V\u00fdzkumn\u00e9 AHK-Cu prod\u00e1van\u00e9 zde je dod\u00e1v\u00e1no <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong> a nen\u00ed ur\u010deno pro lidsk\u00e9 ani veterin\u00e1rn\u00ed pod\u00e1v\u00e1n\u00ed. Pro sestersk\u00fd m\u011b\u010fn\u00fd peptid pro v\u00fdzkum k\u016f\u017ee viz n\u00e1\u0161 <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> produktovou str\u00e1nku.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 Dod\u00e1vka m\u011bdi do papil\u00e1rn\u00edch bun\u011bk vlasov\u00e9ho folikulu<\/h2>\n<p>Co \u010din\u00ed AHK-Cu mechanisticky v\u00fdjime\u010dn\u00fdm mezi m\u011b\u010fn\u00fdmi peptidy, je jeho <strong>preferen\u010dn\u00ed signalizace u bun\u011bk derm\u00e1ln\u00ed papily<\/strong> ve vlasov\u00e9m folikulu \u2014 mezenchym\u00e1ln\u00edch bu\u0148k\u00e1ch na b\u00e1zi ka\u017ed\u00e9ho folikulu, kter\u00e9 reguluj\u00ed tvorbu vlasov\u00e9ho stvolu a proch\u00e1zej\u00ed f\u00e1zemi r\u016fstu (anagenn\u00ed), regrese (katagenn\u00ed) a klidu (telogenn\u00ed). Publikovan\u00fd v\u00fdzkum dokumentuje t\u0159i hlavn\u00ed mechanismy:<\/p>\n<ul>\n<li><strong>Dod\u00e1v\u00e1n\u00ed m\u011bdi do bun\u011bk derm\u00e1ln\u00ed papily<\/strong> \u2014 Ion Cu<sup>2+<\/sup> je \u00fa\u010dinnou slo\u017ekou AHK-Cu (a GHK-Cu ve v\u00fdzkumu k\u016f\u017ee). Tento tripeptid slou\u017e\u00ed jako nosi\u010d, kter\u00fd dopravuje kovov\u00fd iont do c\u00edlov\u00e9 tk\u00e1n\u011b, kde m\u011b\u010f pln\u00ed roli kofaktoru u v\u00edce enzym\u016f v\u010detn\u011b lysyloxid\u00e1zy (zes\u00ed\u0165ov\u00e1n\u00ed kolagenu a elastinu) a superoxiddismut\u00e1zy (tlumen\u00ed oxida\u010dn\u00edho stresu). Ve vlasov\u00e9m folikulu bu\u0148ky derm\u00e1ln\u00ed papily p\u0159ij\u00edmaj\u00ed m\u011b\u010f z AHK-Cu a vyu\u017e\u00edvaj\u00ed ji k podpo\u0159e extracelul\u00e1rn\u00ed matrix folikulu a zvl\u00e1d\u00e1n\u00ed oxida\u010dn\u00edho stresu, kter\u00fd anagenn\u00ed f\u00e1ze vy\u017eaduje.<\/li>\n<li><strong>Upregulace VEGF a vaskularizace folikulu<\/strong> \u2014 AHK-Cu stimuluje expresi vaskul\u00e1rn\u00edho endoteli\u00e1ln\u00edho r\u016fstov\u00e9ho faktoru (VEGF) v bu\u0148k\u00e1ch derm\u00e1ln\u00ed papily. V\u00fdsledn\u00fdm efektem je zv\u00fd\u0161en\u00e1 perfuze folikulu \u2014 r\u016fst nov\u00fdch kapil\u00e1r na b\u00e1zi folikulu, kter\u00fd podporuje metabolick\u00e9 n\u00e1roky rychle se mno\u017e\u00edc\u00edch keratinocyt\u016f vlasov\u00e9 matrix b\u011bhem anagenn\u00ed f\u00e1ze. Tento mechanismus zlep\u0161en\u00ed perfuze se \u010d\u00e1ste\u010dn\u011b p\u0159ekr\u00fdv\u00e1 s mechanismem minoxidilu, ale funguje na zcela odli\u0161n\u00e9 dr\u00e1ze (p\u0159\u00edm\u00e1 signalizace m\u011b\u010f-peptidem nam\u00edsto modulace ATP-senzitivn\u00edch drasl\u00edkov\u00fdch kan\u00e1l\u016f).<\/li>\n<li><strong>Prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze a zv\u011bt\u0161en\u00ed folikulu<\/strong> \u2014 V publikovan\u00e9m v\u00fdzkumu vlasov\u00e9ho cyklu u hlodavc\u016f pod\u00e1v\u00e1n\u00ed AHK-Cu prodlu\u017euje trv\u00e1n\u00ed anagenn\u00ed r\u016fstov\u00e9 f\u00e1ze a zv\u011bt\u0161uje celkovou velikost folikulu. Kombinovan\u00fd efekt znamen\u00e1 v\u011bt\u0161\u00ed produkci vlasov\u00e9ho stvolu na jeden folikul v ka\u017ed\u00e9m cyklu. Mechanismus se zd\u00e1 b\u00fdt nav\u00e1z\u00e1n na kroky dod\u00e1v\u00e1n\u00ed m\u011bdi a upregulace VEGF \u2014 zdrav\u00e9, dob\u0159e prokrven\u00e9 folikuly v prost\u0159ed\u00ed s dostatkem m\u011bdi udr\u017euj\u00ed anagenn\u00ed f\u00e1zi d\u00e9le, ne\u017e p\u0159ejdou do katagenn\u00ed f\u00e1ze.<\/li>\n<\/ul>\n<p>Tento mechanismus se z\u00e1sadn\u011b li\u0161\u00ed od dvou schv\u00e1len\u00fdch l\u00e1tek proti vypad\u00e1v\u00e1n\u00ed vlas\u016f: finasterid blokuje 5-alfa-redukt\u00e1zu, \u010d\u00edm\u017e sni\u017euje hladinu DHT ve poko\u017ece (hormon\u00e1ln\u00ed mechanismus); minoxidil otev\u00edr\u00e1 ATP-senzitivn\u00ed drasl\u00edkov\u00e9 kan\u00e1ly a vazodilatuje c\u00e9vy folikulu (vaskul\u00e1rn\u00ed mechanismus). AHK-Cu poskytuje p\u0159\u00edmou signalizaci mezenchym\u00e1ln\u00edm bu\u0148k\u00e1m a dod\u00e1vku m\u011bdi jako kofaktoru, p\u016fsob\u00edc na jin\u00e9m m\u00edst\u011b ve folikul\u00e1rn\u00ed biologii ne\u017e kter\u00e1koli ze schv\u00e1len\u00fdch l\u00e1tek \u2014 co\u017e z n\u011bj \u010din\u00ed u\u017eite\u010dn\u00fd v\u00fdzkumn\u00fd n\u00e1stroj pro studium bun\u011b\u010dn\u00e9 biologie folikulu nez\u00e1visle na androgenn\u00ed ose nebo mechanismech zprost\u0159edkovan\u00fdch vazodilatac\u00ed. Subkut\u00e1nn\u00ed, topick\u00e9 a intrafollikul\u00e1rn\u00ed injek\u010dn\u00ed pod\u00e1n\u00ed jsou v\u0161echny dokumentov\u00e1ny v publikovan\u00e9m v\u00fdzkumu.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>AHK-Cu se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu ke zkoum\u00e1n\u00ed:<\/p>\n<ul>\n<li><strong>V\u00fdzkum biologie vlasov\u00fdch folikul\u016f<\/strong> \u2014 testy proliferace bun\u011bk derm\u00e1ln\u00ed papily, m\u011b\u0159en\u00ed velikosti folikul\u016f, anal\u00fdza pr\u016fm\u011bru vlasov\u00e9ho stvolu, v\u00fdzkum folikul\u016f kultivovan\u00fdch v org\u00e1nov\u00e9 kultu\u0159e; kanonick\u00e1 m\u011b\u010f-peptidov\u00e1 v\u00fdzkumn\u00e1 slou\u010denina pro vlasovou osu (Pyo et al., J Korean Med Sci 2007; Uno &amp; Kurata, J Investig Dermatol)<\/li>\n<li><strong>V\u00fdzkum cyklu r\u016fstu vlas\u016f<\/strong> \u2014 d\u00e9lka f\u00e1ze anagenn\u00ed\/kategenn\u00ed\/telogenn\u00ed, indukce anagenu v telogenn\u00edch folikulech, srovn\u00e1vac\u00ed d\u00e1vkov\u00e1 odezva se zaveden\u00fdmi kompar\u00e1tory vlasov\u00e9 osy<\/li>\n<li><strong>V\u00fdzkum vaskularizace folikul\u016f<\/strong> \u2014 exprese VEGF, hustota kapil\u00e1r na b\u00e1zi folikulu, m\u011b\u0159en\u00ed perfuze peri-folikul\u00e1rn\u00ed oblasti<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum m\u011bd\u011bn\u00fdch peptid\u016f<\/strong> \u2014 p\u0159\u00edm\u00e9 srovn\u00e1n\u00ed s <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> pro dermatologick\u00fd v\u00fdzkum; AHK-Cu je preferov\u00e1n pro c\u00edle souvisej\u00edc\u00ed s vlasovou osou, GHK-Cu je preferov\u00e1n pro c\u00edle souvisej\u00edc\u00ed s k\u016f\u017e\u00ed\/hojen\u00edm ran\/anti-agingem<\/li>\n<li><strong>V\u00fdzkum topick\u00fdch a intraderm\u00e1ln\u00edch formulac\u00ed<\/strong> \u2014 AHK-Cu je jedn\u00edm z v\u00edce studovan\u00fdch m\u011bd\u011bn\u00fdch peptid\u016f pro topickou a intraderm\u00e1ln\u00ed aplikaci; publikovan\u00e9 studie zkoumaj\u00ed hloubku penetrace do k\u016f\u017ee, c\u00edlen\u00ed na folikuly pomoc\u00ed r\u016fzn\u00fdch nosn\u00fdch formulac\u00ed<\/li>\n<li><strong>Anal\u00fdza mechanism\u016f vypad\u00e1v\u00e1n\u00ed vlas\u016f<\/strong> \u2014 vedle finasteridu (androgenn\u00ed osa) a minoxidilu (vaskul\u00e1rn\u00ed osa) poskytuje AHK-Cu t\u0159et\u00ed ortogon\u00e1ln\u00ed v\u00fdzkumn\u00fd mechanismus (mesenchym\u00e1ln\u00ed bu\u0148ky + m\u011bd\u011bn\u00fd kofaktor + VEGF osa); u\u017eite\u010dn\u00e9 pro v\u00fdzkumn\u00e9 n\u00e1vrhy mechanismu \u00fa\u010dinku<\/li>\n<li><strong>V\u00fdzkum kolagenu a elastinu<\/strong> \u2014 role m\u011bdi jako kofaktoru pro lysyloxid\u00e1zu \u010din\u00ed m\u011bd\u011bn\u00e9 peptidy relevantn\u00ed pro v\u00fdzkum mezibun\u011b\u010dn\u00e9 matrixov\u00e9 p\u0159\u00ed\u010dn\u00e9 vazby; AHK-Cu sd\u00edl\u00ed tento mechanismus s GHK-Cu na obecn\u011bj\u0161\u00ed \u00farovni, i kdy\u017e \u00fa\u010dinky na vlasovou osu p\u0159eva\u017euj\u00ed.<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext o m\u00edst\u011b AHK-Cu v r\u00e1mci v\u00fdzkumu m\u011bd\u011bn\u00fdch peptid\u016f a dermatologie viz <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> jako kanonick\u00fd m\u011b\u010f v\u00e1zaj\u00edc\u00ed peptid pro v\u00fdzkum k\u016f\u017ee, <a href=\"https:\/\/medsbase.com\/cs\/bpc-157\/\">BPC-157<\/a> pro v\u00fdzkum opravy tk\u00e1n\u00ed a <a href=\"https:\/\/medsbase.com\/cs\/tb-500\/\">TB-500<\/a> pro v\u00fdzkum syst\u00e9mov\u00e9 regenerace. Prohl\u00e9dn\u011bte si cel\u00fd <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalog v\u00fdzkumn\u00fdch peptid\u016f<\/a> pro p\u0159\u00edbuzn\u00e9 slou\u010deniny.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase nab\u00edz\u00ed AHK-Cu ve dvou lyofilizovan\u00fdch velikostech vial kalibrovan\u00fdch na typick\u00e9 d\u00e9lky v\u00fdzkumn\u00fdch protokol\u016f. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00ed po 10 nebo 20 vialech s kompletn\u00edm n\u00e1vodem na rekonstituci:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00fd v\u00fdzkumn\u00fd p\u0159\u00edpad u\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 s\u00edla \u2014 topick\u00e1 formulace a protokoly s kr\u00e1tk\u00fdm cyklem<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">V\u011bt\u0161\u00ed v\u00fdzkumn\u00e9 vialy, prodlou\u017een\u00e9 cykly, nejni\u017e\u0161\u00ed cena za mg, v\u00fdzkum vlasov\u00fdch folikul\u016f pro v\u00edce kohort<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 nebo 20 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ob\u011b s\u00edly maj\u00ed stejnou chemickou formu (lyofilizovan\u00fd m\u011b\u010f-peptidov\u00fd komplex, \u010distota 99%+ HPLC). V\u011bt\u0161\u00ed vialy jsou zvl\u00e1\u0161t\u011b u\u017eite\u010dn\u00e9 pro AHK-Cu kv\u016fli relativn\u011b vysok\u00fdm d\u00e1vk\u00e1m typick\u00fdm pro v\u00fdzkum topick\u00fdch formulac\u00ed ve srovn\u00e1n\u00ed se syst\u00e9mov\u00fdmi peptidy v mikrogramov\u00fdch d\u00e1vk\u00e1ch. V\u011bt\u0161\u00ed vialy vy\u017eaduj\u00ed men\u0161\u00ed objemy rekonstituce na jednotku d\u00e1vky.<\/p>\n<h2>Srovn\u00e1n\u00ed \u2014 AHK-Cu vs GHK-Cu<\/h2>\n<p>AHK-Cu a <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> jsou sestersk\u00e9 m\u011b\u010f v\u00e1zaj\u00edc\u00ed tripeptidy, kter\u00e9 sd\u00edlej\u00ed stejnou chemii koordinace m\u011bdi, ale li\u0161\u00ed se v prvn\u00ed aminokyselin\u011b (Ala vs Gly). Tento drobn\u00fd struktur\u00e1ln\u00ed rozd\u00edl vytv\u00e1\u0159\u00ed kvalitativn\u011b odli\u0161n\u00e9 v\u00fdzkumn\u00e9 sign\u00e1ly: GHK-Cu dominuje ve v\u00fdzkumu k\u016f\u017ee\/ran\/st\u00e1rnut\u00ed, zat\u00edmco nejsiln\u011bj\u0161\u00ed sign\u00e1l AHK-Cu je v biologii vlasov\u00fdch folikul\u016f.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">AHK-Cu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHK-Cu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9lka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 aminokyseliny (tripeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 aminokyseliny (tripeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-His-Lys<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gly-His-Lys<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Koordinace m\u011bdi<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> p\u0159es His + N-terminus<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> p\u0159es His + N-terminus<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e1rn\u00ed v\u00fdzkumn\u00fd sign\u00e1l<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biologie vlasov\u00e9ho folikulu, prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u0159estavba k\u016f\u017ee, hojen\u00ed ran, proti st\u00e1rnut\u00ed<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>C\u00edlov\u00fd typ bu\u0148ky<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bu\u0148ky derm\u00e1ln\u00ed papily (vlasov\u00fd folikul)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Derm\u00e1ln\u00ed fibroblasty, keratinocyty (k\u016f\u017ee)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Signalizace VEGF<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Siln\u00e1 \u2014 folikul\u00e1rn\u00ed vaskularizace<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">St\u0159edn\u00ed \u2014 angiogeneze v r\u00e1n\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Endogenn\u00ed v\u00fdskyt<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Syntetick\u00fd (\u017e\u00e1dn\u00e1 v\u00fdznamn\u00e1 endogenn\u00ed z\u00e1soba)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Endogenn\u00ed (s v\u011bkem kles\u00e1 v plazm\u011b)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u201310 mg topicky \/ 1\u20135 mg subkut\u00e1nn\u011b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20135 mg topicky \/ 0,5\u20132 mg subkut\u00e1nn\u011b<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pro v\u00fdzkum vlasov\u00e9 osy je AHK-Cu kanonickou prvn\u00ed volbou d\u00edky selektivit\u011b pro bu\u0148ky derm\u00e1ln\u00ed papily a zdokumentovan\u00e9mu sign\u00e1lu prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze. Pro v\u00fdzkum p\u0159estavby k\u016f\u017ee, hojen\u00ed ran a proti st\u00e1rnut\u00ed, <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> je kanonick\u00fdm referen\u010dn\u00edm materi\u00e1lem. N\u011bkter\u00e9 v\u00fdzkumn\u00e9 designy pou\u017e\u00edvaj\u00ed ob\u011b varianty paraleln\u011b, aby odd\u011blily efekty m\u011b\u010f-peptid\u016f, kter\u00e9 jsou spole\u010dn\u00e9 (obecn\u00e9 dod\u00e1n\u00ed m\u011bdi jako kofaktoru), od efekt\u016f specifick\u00fdch pro sekvenci (selektivita v\u016f\u010di bun\u011b\u010dn\u00e9mu typu).<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> lyofilizovan\u00e9 lahvi\u010dky skladujte v chladni\u010dce p\u0159i teplot\u011b 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu pro kr\u00e1tkodob\u00e9 pracovn\u00ed z\u00e1soby. Pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch lahvi\u010dek zmrazte p\u0159i \u221220 \u00b0C. Lyofilizovan\u00fd AHK-Cu je stabiln\u00ed v chladni\u010dce a\u017e 24 m\u011bs\u00edc\u016f a p\u0159i \u221220 \u00b0C a\u017e 36 m\u011bs\u00edc\u016f. Vyvarujte se cykl\u016f rozmrazov\u00e1n\u00ed a zmrazov\u00e1n\u00ed lyofilizovan\u00e9ho pr\u00e1\u0161ku. M\u011b\u010f<sup>2+<\/sup> koordinace je stabiln\u00ed v lyofilizovan\u00e9 form\u011b; po rekonstituci m\u016f\u017ee prodlou\u017een\u00e1 expozice sv\u011btlu nebo reduk\u010dn\u00edm \u010dinidl\u016fm ovlivnit oxida\u010dn\u00ed stav m\u011bdi.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> injektujte bakteriostatickou vodu po st\u011bn\u011b lahvi\u010dky s peptidem (ne p\u0159\u00edmo na lyofilizovan\u00fd kol\u00e1\u010d). Pro lahvi\u010dku 20 mg, 2,0 mL bakteriostatick\u00e9 vody vytvo\u0159\u00ed pracovn\u00ed koncentraci 10 mg\/mL \u2014 0,1 mL dod\u00e1 1 mg; 0,5 mL dod\u00e1 5 mg. Jemn\u011b zakru\u017ete \u2014 ne <strong>ne<\/strong> prot\u0159ep\u00e1vejte \u2014 a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok by m\u011bl b\u00fdt \u010dir\u00fd s charakteristickou modrou barvou v\u00e1zan\u00e9 m\u011bdi. Z\u00e1kal nebo sra\u017eenina indikuj\u00ed probl\u00e9m s rekonstituc\u00ed; zlikvidujte a zkuste znovu.<sup>2+<\/sup>. Z\u00e1kal nebo sra\u017eenina nazna\u010duje probl\u00e9m s rekonstituc\u00ed; zlikvidujte a zkuste to znovu.<\/p>\n<p><strong>Po rekonstituci:<\/strong> Uchov\u00e1vejte v chladni\u010dce p\u0159i teplot\u011b 2\u20138 \u00b0C a spot\u0159ebujte do 30 dn\u016f pro optim\u00e1ln\u00ed stabilitu. Rekonstituovan\u00fd roztok nezmrazujte \u2014 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed naru\u0161uj\u00ed integritu peptidu. Chra\u0148te v\u017edy p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem. Pro v\u00fdzkum topick\u00fdch formulac\u00ed lze AHK-Cu za\u010dlenit do \u0161irok\u00e9 \u0161k\u00e1ly nosi\u010d\u016f (kr\u00e9my, gely, s\u00e9ra) pro dod\u00e1n\u00ed do vlasov\u00fdch folikul\u016f; publikovan\u00fd v\u00fdzkum nosi\u010d\u016f zahrnuje liposom\u00e1ln\u00ed a mikroemulzn\u00ed formulace pro zv\u00fd\u0161enou penetraci do folikul\u016f.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se AHK-Cu pou\u017e\u00edv\u00e1 ve v\u00fdzkumu?<\/h3>\n<p>AHK-Cu se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zkoumaj\u00edc\u00edm biologii vlasov\u00fdch folikul\u016f, proliferaci bun\u011bk derm\u00e1ln\u00ed papily, prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze, folikul\u00e1rn\u00ed vaskularizaci, pr\u016fm\u011br vlasov\u00e9ho stvolu, srovn\u00e1vac\u00ed farmakologii m\u011b\u010f-peptid\u016f, v\u00fdzkum topick\u00fdch a intraderm\u00e1ln\u00edch formulac\u00ed a rozbor mechanismu \u00fa\u010dinku biologie vypad\u00e1v\u00e1n\u00ed vlas\u016f odli\u0161n\u00e9 od mechanism\u016f androgenn\u00ed osy (finasteride) a vaskul\u00e1rn\u00edch mechanism\u016f (minoxidil). Je to kanonick\u00e1 v\u00fdzkumn\u00e1 slou\u010denina m\u011b\u010f-peptidu pro vlasovou osu. Zde prod\u00e1van\u00fd AHK-Cu v\u00fdzkumn\u00e9 kvality je <strong>ne<\/strong> schv\u00e1len\u00fd FDA a je dod\u00e1v\u00e1n v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkumn\u00e9 \u00fa\u010dely.<\/p>\n<h3>Jak se AHK-Cu li\u0161\u00ed od GHK-Cu?<\/h3>\n<p>Oba jsou tripeptidy v\u00e1zaj\u00edc\u00ed m\u011b\u010f, kter\u00e9 sd\u00edlej\u00ed stejnou architekturu koordinace Cu (zprost\u0159edkovanou His v pom\u011bru 1:1 Cu<sup>2+<\/sup> Nejsiln\u011bj\u0161\u00ed v\u00fdzkumn\u00fd sign\u00e1l AHK-Cu je u derm\u00e1ln\u00edch papil\u00e1rn\u00edch bun\u011bk vlasov\u00e9ho folikulu; nejsiln\u011bj\u0161\u00ed sign\u00e1l GHK-Cu je u ko\u017en\u00edch fibroblast\u016f a keratinocyt\u016f. Tyto dva peptidy jsou \u010dasto studov\u00e1ny paraleln\u011b, aby bylo mo\u017en\u00e9 odd\u011blit spole\u010dn\u00e9 \u00fa\u010dinky m\u011b\u010f-peptid\u016f od \u00fa\u010dink\u016f specifick\u00fdch pro sekvenci.; <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a>\u2018s nejsiln\u011bj\u0161\u00ed sign\u00e1l je v ko\u017en\u00edch fibroblastech a keratinocytech. Tyto dv\u011b jsou \u010dasto studov\u00e1ny paraleln\u011b, aby se odli\u0161ily sd\u00edlen\u00e9 \u00fa\u010dinky m\u011b\u010f-peptid\u016f od \u00fa\u010dink\u016f specifick\u00fdch pro sekvenci.<\/p>\n<h3>Jak\u00e1 je typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka AHK-Cu?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly obvykle pou\u017e\u00edvaj\u00ed 1\u20135\u00a0mg na pod\u00e1n\u00ed pro subkut\u00e1nn\u00ed aplikaci a 2\u201310\u00a0mg pro v\u00fdzkum topick\u00fdch formulac\u00ed, pod\u00e1van\u00e9 1\u20133kr\u00e1t denn\u011b po dobu 4\u201312t\u00fddenn\u00edch v\u00fdzkumn\u00fdch cykl\u016f. 20mg injek\u010dn\u00ed lahvi\u010dka rekonstituovan\u00e1 2,0\u00a0ml bakteriostatick\u00e9 vody poskytuje koncentraci 10\u00a0mg\/ml \u2014 0,1\u00a0ml odpov\u00edd\u00e1 1\u00a0mg, 0,5\u00a0ml odpov\u00edd\u00e1 5\u00a0mg.<\/p>\n<h3>Ne. AHK-Cu nen\u00ed schv\u00e1leno FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. M\u011b\u010f-peptidy byly za\u010dlen\u011bny do n\u011bkter\u00fdch kosmetick\u00fdch produkt\u016f v r\u00e1mci kosmetick\u00fdch regulac\u00ed, ale AHK-Cu konkr\u00e9tn\u011b nem\u00e1 \u017e\u00e1dn\u00e9 terapeutick\u00e9 schv\u00e1len\u00ed. Ve\u0161ker\u00e9 AHK-Cu prod\u00e1van\u00e9 dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010deno pro laboratorn\u00ed v\u00fdzkum a nem\u011blo by b\u00fdt pod\u00e1v\u00e1no lidem.<\/h3>\n<p>Ne. AHK-Cu nen\u00ed schv\u00e1leno FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm v\u00fdznamn\u00fdm regula\u010dn\u00edm org\u00e1nem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. M\u011b\u010fnat\u00e9 peptidy byly za\u010dlen\u011bny do n\u011bkter\u00fdch kosmetick\u00fdch produkt\u016f v r\u00e1mci kosmetick\u00fdch regula\u010dn\u00edch r\u00e1mc\u016f, ale AHK-Cu konkr\u00e9tn\u011b nem\u00e1 \u017e\u00e1dn\u00e9 terapeutick\u00e9 schv\u00e1len\u00ed. Ve\u0161ker\u00e9 AHK-Cu prod\u00e1van\u00e9 dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010deno pro laboratorn\u00ed v\u00fdzkum a nem\u011blo by b\u00fdt pod\u00e1v\u00e1no lidem.<\/p>\n<h3>Lyofilizovan\u00e9 lahvi\u010dky: kr\u00e1tkodob\u011b skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, dlouhodob\u011b neotev\u0159en\u00e9 lahvi\u010dky p\u0159i \u221220 \u00b0C. Rekonstituovan\u00fd roztok: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C a pou\u017eijte do 30 dn\u016f. Rekonstituovan\u00fd roztok nezmrazujte \u2014 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed degraduj\u00ed peptid a mohou ovlivnit koordinaci m\u011bdi. V\u017edy chra\u0148te p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem, abyste zachovali oxida\u010dn\u00ed stav m\u011bdi.<\/h3>\n<p>Lyofilizovan\u00e9 injek\u010dn\u00ed lahvi\u010dky: uchov\u00e1vejte p\u0159i teplot\u011b 2\u20138 \u00b0C pro kr\u00e1tkodobou pracovn\u00ed z\u00e1sobu, nebo p\u0159i \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch lahvi\u010dek. Rekonstituovan\u00fd roztok: uchov\u00e1vejte p\u0159i teplot\u011b 2\u20138 \u00b0C, spot\u0159ebujte do 30 dn\u016f. Rekonstituovan\u00fd roztok nezmrazujte \u2013 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed degraduj\u00ed peptid a mohou ovlivnit koordinaci m\u011bdi. Chra\u0148te v\u017edy p\u0159ed p\u0159\u00edm\u00fdm sv\u011btlem, aby se zachoval oxida\u010dn\u00ed stav m\u011bdi.<\/p>\n<h3>Prot\u0159epejte lahvi\u010dku. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok je \u010dir\u00fd s charakteristickou modrou barvou v\u00e1zan\u00e9 m\u011bdi \u2014 barva sama potvrzuje \u00fasp\u011b\u0161nou rekonstituci a neporu\u0161enou koordinaci m\u011bdi. Pro lahvi\u010dku 20 mg + 2,0 mL \u0159edidla je pracovn\u00ed koncentrace 10 mg\/mL.<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho rekonstitu\u010dn\u00edho postupu. P\u0159idejte bakteriostatickou vodu po st\u011bn\u011b lahvi\u010dky (ne p\u0159\u00edmo na lyofilizovan\u00fd pr\u00e1\u0161ek), jemn\u011b prot\u0159epejte a nechte 2\u20135 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Ne <strong>ne<\/strong> lahvi\u010dku prot\u0159epejte. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok je \u010dir\u00fd s charakteristickou modrou barvou v\u00e1zan\u00e9 m\u011bdi<sup>2+<\/sup> \u2014 samotn\u00e1 barva potvrzuje \u00fasp\u011b\u0161nou rekonstituci a neporu\u0161enou koordinaci m\u011bdi. Pro 20 mg lahvi\u010dku + 2.0 mL rozpou\u0161t\u011bdla je pracovn\u00ed koncentrace 10 mg\/mL.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed AHK-Cu v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch o obsahu 20 mg a 50 mg. Ka\u017ed\u00e1 s\u00edla je k dispozici v balen\u00ed po 10 nebo 20 lahvi\u010dk\u00e1ch. V\u0161echny lahvi\u010dky jsou dod\u00e1v\u00e1ny s \u010distotou 99%+ dle HPLC a s certifik\u00e1tem anal\u00fdzy dostupn\u00fdm na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Pro\u010d m\u00e1 AHK-Cu modrou barvu?<\/h3>\n<p>Charakteristick\u00e1 modrofialov\u00e1 barva AHK-Cu (a GHK-Cu) poch\u00e1z\u00ed z d-d elektronick\u00fdch p\u0159echod\u016f v\u00e1zan\u00e9 Cu<sup>2+<\/sup> v \u010dtvercov\u011b plan\u00e1rn\u00edm koordina\u010dn\u00edm prost\u0159ed\u00ed vytvo\u0159en\u00e9m histidinov\u00fdm zbytkem a peptidovou kostrou. Barva je u\u017eite\u010dn\u00fdm kvalitativn\u00edm ukazatelem \u00fasp\u011b\u0161n\u00e9 koordinace m\u011bdi \u2013 spr\u00e1vn\u011b rekonstituovan\u00fd modr\u00fd roztok potvrzuje intaktn\u00ed vazbu Cu<sup>2+<\/sup> zat\u00edmco bezbarv\u00fd nebo sv\u011btl\u00fd roztok by nazna\u010doval ztr\u00e1tu nebo degradaci m\u011bdi. To je mezi mal\u00fdmi peptidy unik\u00e1tn\u00ed \u2013 v\u011bt\u0161ina syntetick\u00fdch peptid\u016f po rekonstituci poskytuje bezbarv\u00e9 roztoky.<\/p>\n<h3>Jak se AHK-Cu srovn\u00e1v\u00e1 s finasteridem nebo minoxidilem?<\/h3>\n<p>Tyto t\u0159i l\u00e1tky p\u016fsob\u00ed na biologii vypad\u00e1v\u00e1n\u00ed vlas\u016f zcela odli\u0161n\u00fdmi mechanismy. Finasterid blokuje 5-alfa-redukt\u00e1zu, \u010d\u00edm\u017e sni\u017euje hladiny dihydrotestosteronu (DHT) ve poko\u017ece hlavy \u2013 jde o androgenn\u00ed mechanismus. Minoxidil otev\u00edr\u00e1 ATP-senzitivn\u00ed drasl\u00edkov\u00e9 kan\u00e1ly a zp\u016fsobuje vazodilataci folikul\u00e1rn\u00edch c\u00e9v \u2013 jde o vaskul\u00e1rn\u00ed mechanismus. AHK-Cu poskytuje p\u0159\u00edm\u00e9 dod\u00e1n\u00ed m\u011b\u010fn\u00e9ho kofaktoru a VEGF-zprost\u0159edkovanou vaskularizaci folikul\u016f na \u00farovni bun\u011bk derm\u00e1ln\u00ed papily \u2013 jde o mezenchym\u00e1ln\u00ed bun\u011b\u010dn\u00fd mechanismus. Tyto t\u0159i mechanismy jsou ortogon\u00e1ln\u00ed, co\u017e \u010din\u00ed z AHK-Cu u\u017eite\u010dn\u00fd v\u00fdzkumn\u00fd n\u00e1stroj pro studium folikul\u00e1rn\u00ed biologie nez\u00e1visl\u00e9 na androgenn\u00edch nebo vazodilata\u010dn\u00edch \u00fa\u010dinc\u00edch.<\/p>\n<h3>Zp\u016fsobuje AHK-Cu ve v\u00fdzkumu vedlej\u0161\u00ed \u00fa\u010dinky?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 studie uv\u00e1d\u011bj\u00ed v\u00fdrazn\u011b \u010dist\u00fd bezpe\u010dnostn\u00ed profil p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch, p\u0159i\u010dem\u017e hlavn\u00edm c\u00edlov\u00fdm \u00fa\u010dinkem je stimulace folikul\u016f. Mezi ne\u017e\u00e1douc\u00ed \u00fa\u010dinky m\u016f\u017ee pat\u0159it lok\u00e1ln\u00ed podr\u00e1\u017ed\u011bn\u00ed v m\u00edst\u011b vpichu a (p\u0159i dlouhodob\u00e9 vysokod\u00e1vkov\u00e9 topick\u00e9 expozici) m\u00edrn\u00e9 ko\u017en\u00ed zabarven\u00ed zp\u016fsoben\u00e9 ukl\u00e1d\u00e1n\u00edm m\u011bdi \u2013 oboj\u00ed je reverzibiln\u00ed po vysazen\u00ed. Syst\u00e9mov\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky p\u0159i topick\u00e9 aplikaci jsou vz\u00e1cn\u00e9 kv\u016fli omezen\u00e9 transkut\u00e1nn\u00ed absorpci.<\/p>\n<h3>Jak\u00fd je polo\u010das rozpadu AHK-Cu?<\/h3>\n<p>V preklinick\u00e9m v\u00fdzkumu m\u00e1 AHK-Cu relativn\u011b kr\u00e1tk\u00fd plazmatick\u00fd polo\u010das (~1\u20132 hodiny) po subkut\u00e1nn\u00ed aplikaci. Kr\u00e1tk\u00fd polo\u010das je kompenzov\u00e1n retenc\u00ed v\u00e1zan\u00e9 m\u011bdi v c\u00edlov\u00fdch tk\u00e1n\u00edch \u2013 i po clearance z plazmy m\u011b\u010f dodan\u00e1 do bun\u011bk derm\u00e1ln\u00ed papily nad\u00e1le podporuje folikul\u00e1rn\u00ed biologii prost\u0159ednictv\u00edm sv\u00fdch enzymatick\u00fdch kofaktorov\u00fdch rol\u00ed. Topick\u00e9 formy poskytuj\u00ed trvalou lok\u00e1ln\u00ed expozici, kter\u00e1 je pro v\u00fdzkum vlasov\u00e9ho cyklu relevantn\u011bj\u0161\u00ed ne\u017e syst\u00e9mov\u00fd plazmatick\u00fd profil.<\/p>\n<h3>Lze AHK-Cu a GHK-Cu kombinovat ve v\u00fdzkumu?<\/h3>\n<p>Ano. Tyto dva m\u011b\u010fn\u00e9 peptidy c\u00edl\u00ed na r\u016fzn\u00e9 bun\u011b\u010dn\u00e9 typy (derm\u00e1ln\u00ed papilu u AHK-Cu, derm\u00e1ln\u00ed fibroblasty u GHK-Cu) a \u0159e\u0161\u00ed r\u016fzn\u00e9 v\u00fdzkumn\u00e9 oblasti (vlasy vs. k\u016f\u017ee), tak\u017ee jejich spole\u010dn\u00e1 aplikace nen\u00ed farmakologicky redundantn\u00ed. V\u00fdzkumn\u00e9 protokoly studuj\u00edc\u00ed kombinovan\u00e9 ko\u017en\u00ed a vlasov\u00e9 parametry \u2013 nap\u0159\u00edklad komplexn\u00ed v\u00fdzkum dermatologick\u00e9ho remodelov\u00e1n\u00ed \u2013 n\u011bkdy vyu\u017e\u00edvaj\u00ed ob\u011b slo\u017eky.<\/p>\n<h3>Jak dlouho trv\u00e1, ne\u017e se \u00fa\u010dinky AHK-Cu projev\u00ed v preklinick\u00e9m v\u00fdzkumu?<\/h3>\n<p>Akutn\u00ed \u00fa\u010dinky na expresi VEGF v bu\u0148k\u00e1ch derm\u00e1ln\u00ed papily jsou detekovateln\u00e9 b\u011bhem 24\u201372 hodin ve v\u00fdzkumu bun\u011b\u010dn\u00fdch kultur. \u00da\u010dinky na velikost folikul\u016f a prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze v modelech vlasov\u00e9ho cyklu u hlodavc\u016f obvykle dos\u00e1hnou statistick\u00e9 v\u00fdznamnosti po 4\u20138 t\u00fddnech pravideln\u00e9 l\u00e9\u010dby a d\u00e1le se zvy\u0161uj\u00ed po dobu 12\u201316 t\u00fddn\u016f \u2013 co\u017e odpov\u00edd\u00e1 p\u0159irozen\u00e9mu \u010dasov\u00e9mu r\u00e1mci vlasov\u00e9ho cyklu.<\/p>\n<h3>Mohu si objednat AHK-Cu pro mezin\u00e1rodn\u00ed p\u0159epravu?<\/h3>\n<p>Ano. MedsBase expeduje AHK-Cu do cel\u00e9ho sv\u011bta prost\u0159ednictv\u00edm na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Objedn\u00e1vky obsahuj\u00edc\u00ed pouze peptidy se kvalifikuj\u00ed pro na\u0161i samostatnou slu\u017ebu p\u0159epravy peptid\u016f. V\u0161echny objedn\u00e1vky jsou odes\u00edl\u00e1ny v teplotn\u011b kontrolovan\u00e9m balen\u00ed s pln\u00fdm sledov\u00e1n\u00edm a jsou pokryty na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum vlas\u016f, poko\u017eky a regenerace tk\u00e1n\u00ed<\/h2>\n<ul>\n<li><a href=\"\/cs\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Sestersk\u00fd m\u011b\u010f-v\u00e1zaj\u00edc\u00ed tripeptid \u2014 kanonick\u00e1 slou\u010denina pro v\u00fdzkum remodelace k\u016f\u017ee a hojen\u00ed ran<\/li>\n<li><a href=\"\/cs\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 T\u011blesn\u00fd ochrann\u00fd peptid \u2014 v\u00fdzkum regenerace tk\u00e1n\u00ed a zotaven\u00ed<\/li>\n<li><a href=\"\/cs\/tb-500\/\"><strong>TB-500 (Thymosin Beta-4)<\/strong><\/a> \u2014 Syst\u00e9mov\u00fd hojiv\u00fd fragment \u2014 v\u00fdzkum regenerace tk\u00e1n\u00ed a c\u00e9v<\/li>\n<li><a href=\"\/cs\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pine\u00e1ln\u00ed tetrapeptid \u2014 v\u00fdzkum dlouhov\u011bkosti a cirkadi\u00e1nn\u00edch rytm\u016f<\/li>\n<li><a href=\"\/cs\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropn\u00ed heptapeptid \u2014 v\u00fdzkumn\u00e1 slou\u010denina pro CNS<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Prozkoumejte v\u00fdzkumnou oblast m\u011b\u010f-peptid\u016f<\/strong><\/p>\n<p style=\"margin: 0;\">Prohl\u00e9dn\u011bte si celou <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\"><strong>katalog v\u00fdzkumn\u00fdch peptid\u016f<\/strong><\/a>, s p\u0159\u00edbuzn\u00fdmi dermatologick\u00fdmi a tk\u00e1\u0148ov\u011b-regenera\u010dn\u00edmi slou\u010deninami v\u010detn\u011b <a href=\"https:\/\/medsbase.com\/cs\/ghk-cu\/\">GHK-Cu<\/a> (sestersk\u00fd m\u011b\u010f-peptid pro v\u00fdzkum k\u016f\u017ee), <a href=\"https:\/\/medsbase.com\/cs\/bpc-157\/\">BPC-157<\/a> (regenerace tk\u00e1n\u00ed), a <a href=\"https:\/\/medsbase.com\/cs\/tb-500\/\">TB-500<\/a> (syst\u00e9mov\u00e9 hojen\u00ed).<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Alanyl-Histidyl-Lysin M\u011b\u010f(II) tripeptid<br \/>\n\u2705 Sestersk\u00e1 molekula k GHK-Cu<br \/>\n\u2705 V\u00fdzkumn\u00e1 slou\u010denina pro biologii vlasov\u00fdch folikul\u016f<br \/>\n\u2705 Stimulace derm\u00e1ln\u00edch papil\u00e1rn\u00edch bun\u011bk, prodlou\u017een\u00ed anagenn\u00ed f\u00e1ze<br \/>\n\u2705 Ortogon\u00e1ln\u00ed k mechanism\u016fm finasteridu\/minoxidilu<\/p>\n<p><strong>AHK-Cu<\/strong> obsahuje syntetick\u00fd m\u011b\u010f-peptidov\u00fd komplex.<\/p>","protected":false},"featured_media":70940,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6290,5441],"class_list":{"0":"post-70789","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-ahk-cu","8":"product_tag-peptide","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/70789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=70789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70940"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=70789"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=70789"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=70789"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=70789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}